Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Zacks Investment Research downgraded Central Garden & Pet Company ( CENT - Analyst Report ) to a Zacks Rank #5 (Strong Sell) on Jan 15, 2013.
Why the Downgrade?
Central Garden & Pet Company witnessed sharp downward revision in estimates after posting dismal fourth-quarter fiscal 2012 results. The company’s quarterly loss of 21 cents a share remained flat with the prior-year quarter loss, but was a penny wider than the Zacks Consensus Estimate.
Disappointing bottom-line performance compelled management to take a cautious stance on its outlook. Central Garden & Pet Company anticipates sales and earnings for the first quarter of fiscal 2013 to be lower than the comparable prior-year period due to the adverse impact of Hurricane Sandy that greatly affected the Pet segment.
Central Garden has missed the Zacks Consensus Estimate in 8 of the trailing 10 quarters. The average surprise over the last 10 quarters remained negative at 48.3%.
The Zacks Consensus Estimate of a loss of 28 cents for the first quarter of fiscal 2013 widened by 6 cents in the last 60 days. However, for the second quarter, the Zacks Consensus Estimate remained constant at 54 cents. Moreover, for fiscal 2013 and 2014, the Zacks Consensus Estimate fell by 8.1% and 8.8% to 79 cents and $1.03 per share, respectively, over the same time frame.
Other Stocks to Consider
Not all providers of consumer discretionary products are performing as disappointingly as Central Garden & Pet Company. SodaStream International Ltd. ( SODA - Snapshot Report ) holding a Zacks Rank #1 (Strong Buy) is expected to continue with its positive earnings surprise trend in the upcoming quarters. Further, Jarden Corp. ( JAH - Snapshot Report ) and Spectrum Brands Holdings, Inc. ( SPB - Snapshot Report ) , both holding a Zacks Rank #2 (Buy), look promising.
Read the full reports :
Analyst Report on CENT
Snapshot Report on JAH
Snapshot Report on SODA
Snapshot Report on SPB